Jiangxi Shimei Pharmaceutical Co., Ltd.

Primary objective: To investigate the pharmacokinetic characteristics of the test formulation and the reference formulation in healthy adult participants in China under fasting conditions, and to evaluate their bioequivalence under fasting conditions. Secondary objective: To assess the safety of the test formulation and the reference formulation in healthy adult participants in China.

Primary objective: To investigate the pharmacokinetic characteristics of the test formulation and the reference formulation in healthy adult participants in China under fasting and postprandial conditions, and to evaluate the bioequivalence of the two formulations under fasting and postprandial conditions. Secondary objective: To assess the safety of the test formulation and the reference formulation in healthy adult participants in China.

The primary study objective was to investigate the pharmacokinetic characteristics of the test and reference formulations in healthy Chinese adults after oral administration in the fasting and fed states, and to evaluate the bioequivalence of the two formulations after oral administration in the fasting and fed states. The secondary study objective was to evaluate the safety of the test and reference formulations in healthy Chinese adults.